Press Release: Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Elsevier<%2Fa>,%20a%20world-leading%20provider%20of%20scientific,%20technical%20and%20medical%20information%20products%20and%20services,%20announced%20today%20the%20acquisition%20of InferMed<%2Fa>,%20a%20London-based%20clinical%20decision%20support%20(CDS)%20technology%20company.%0D%0A%0D%0Ahttps%3A%2F%2Fwww.bookbusinessmag.com%2Farticle%2Felsevier-acquires-infermed-provider-clinical-decision-support-technology%2F" target="_blank" class="email" data-post-id="19565" type="icon_link">
Email
Email
0 Comments
Comments
"Together, with the global reach of Elsevier, we can further address the needs of acute and primary care institutions. We have a greater opportunity to meet that need as a part of Elsevier Clinical Solutions," Dunlop said.
InferMed is headquartered in London and has employees in France, Australia and New Zealand. The acquisition is effective immediately and financial terms of the transaction are not being disclosed.
0 Comments
View Comments
- People:
- Jay Katzen
- Robert Dunlop
- Places:
- London
- PHILADELPHIA, PA
- UK
Related Content
Comments